Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 12, 2008Heart

Treatment with immunoglobulin and aspirin effectively reduces cardiac complications from 25% to 4.7% in the UK.

View Full Paper
Ask AI
Bookmark
Share

Population

Young children and adolescents with Kawasaki disease

Design

Review

Authors

LWLawrence E. WoodRTRobert Tulloh

Discussion

Loading...

Member takes

Overview

Supports standard therapy in Kawasaki disease; leaves open need for updated prospective trials.

Structured PICO

P
Population
Young children and adolescents with Kawasaki disease
I
Intervention
Immunoglobulin and aspirin

This review provides a comprehensive overview of Kawasaki disease in children, highlighting that standard treatment with immunoglobulin and aspirin significantly reduces cardiac complications.

Cite This Study

Wood et al. (2008) studied this question.

synapsesocial.com/papers/6a8cfb845ab75fc7bb2797e7https://doi.org/10.1136/hrt.2008.143669
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Kawasaki disease: diagnosis, management and cardiac sequelae2007 · 12 citations
  2. 2Kawasaki Disease2007 · 52 citations
  3. 3Kawasaki Disease: Contemporary Clinical Approaches and Challenges2026
  4. 4Kawasaki Disease2009 · 56 citations
  5. 5Coronary artery changes in patients with Kawasaki disease2004 · 14 citations